Idiopathic pulmonary fibrosis: Evolving concepts

Mayo Clinic Proceedings

Volumn 89, Issue 8, 2014, Pages 1130-1142

  Ryu, Jay H ^a   Moua, Teng ^a   Daniels, Craig E ^a   Hartman, Thomas E ^a   Yi, Eunhee S ^a   Utz, James P ^a   Limper, Andrew H ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTIFIBROTIC AGENT; AZATHIOPRINE; COLCHICINE; ETANERCEPT; GAMMA INTERFERON; IMATINIB; PIRFENIDONE; PREDNISONE; THALIDOMIDE; WARFARIN;

ANTICOAGULANT THERAPY; ARTIFICIAL VENTILATION; BRONCHOSCOPY; CLINICAL FEATURE; COMBINED PULMONARY FIBROSIS AND EMPHYSEMA; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; COUGHING; DISEASE COURSE; DISEASE EXACERBATION; DRUG EFFICACY; FIBROSING ALVEOLITIS; GASTROESOPHAGEAL REFLUX; HISTOPATHOLOGY; HUMAN; INCIDENCE; INTERSTITIAL PNEUMONIA; LABORATORY DIAGNOSIS; LUNG BIOPSY; LUNG CANCER; LUNG EMPHYSEMA; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG TRANSPLANTATION; MEDICAL TERMINOLOGY; NONHUMAN; OXYGEN THERAPY; PATHOGENESIS; PROGNOSIS; PULMONARY HYPERTENSION; RESPIRATORY FAILURE; REVIEW; THORAX RADIOGRAPHY; USUAL INTERSTITIAL PNEUMONIA;

AGED; BIOPSY; BLOOD SEDIMENTATION; COMORBIDITY; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; EMPHYSEMA; GASTROESOPHAGEAL REFLUX; HUMANS; HYPERTENSION, PULMONARY; IDIOPATHIC PULMONARY FIBROSIS; LUNG; LUNG NEOPLASMS; MIDDLE AGED; PUBMED; RESPIRATORY FUNCTION TESTS; TOMOGRAPHY, X-RAY COMPUTED; UNITED STATES;

EID: 84905496408     PISSN: 00256196     EISSN: 19425546     Source Type: Journal    
DOI: 10.1016/j.mayocp.2014.03.016     Document Type: Review

References (142)

1. J.H. Ryu, T.V. Colby, and T.E. Hartman Idiopathic pulmonary fibrosis: current concepts Mayo Clin Proc 73 11 1998 1085 1101
2. American Thoracic Society Idiopathic pulmonary fibrosis: diagnosis and treatment; international consensus statement Am J Respir Crit Care Med 161 2, pt 1 2000 646 664
3. G. Raghu, H.R. Collard, J.J. Egan ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis; evidence-based guidelines for diagnosis and management Am J Respir Crit Care Med 183 6 2011 788 824
4. W.D. Travis, U. Costabel, D.M. Hansell ATS/ERS Committee on Idiopathic Interstitial Pneumonias An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias Am J Respir Crit Care Med 188 6 2013 733 748
5. H.R. Collard, and T.E. King Jr. Demystifying idiopathic interstitial pneumonia Arch Intern Med 163 1 2003 17 29
6. American Thoracic Society European Respiratory Society. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias [published correction appears in Am J Respir Crit Care Med. 2002;166(3):426] Am J Respir Crit Care Med 165 2 2002 277 304
7. A.L. Katzenstein, and J.L. Myers Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification Am J Respir Crit Care Med 157 4, pt 1 1998 1301 1315
8. L. Hamman, and A.R. Rich Fulminating diffuse interstitial fibrosis of the lungs Trans Am Clin Climatol Assoc 51 1935 154 163
9. J.A. Bjoraker, J.H. Ryu, and M.K. Edwin et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 157 1 1998 199 203
10. S. Nagai, M. Kitaichi, H. Itoh, K. Nishimura, T. Izumi, and T.V. Colby Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP [published correction appears in Eur Respir J. 1999;13(3):711] Eur Respir J 12 5 1998 1010 1019
11. Z.D. Daniil, F.C. Gilchrist, and A.G. Nicholson et al. A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis Am J Respir Crit Care Med 160 3 1999 899 905
12. M. Selman, T.E. King, and A. Pardo American Thoracic Society; European Respiratory Society; American College of Chest Physicians. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy Ann Intern Med 134 2 2001 136 151
13. R.M. du Bois Strategies for treating idiopathic pulmonary fibrosis Nat Rev Drug Discov 9 2 2010 129 140
14. T.S. Blackwell, A.M. Tager, and Z. Borok et al. Future directions in idiopathic pulmonary fibrosis research: an NHLBI workshop report Am J Respir Crit Care Med 189 2 2014 214 222
15. I.O. Rosas, R.M. Kottman, and P.J. Sime New light is shed on the enigmatic origin of the lung myofibroblast Am J Respir Crit Care Med 188 7 2013 765 766
16. S.H. Phan Genesis of the myofibroblast in lung injury and fibrosis Proc Am Thorac Soc 9 3 2012 148 152
17. Xia H, Bodempudi V, Benyumov A, et al. Identification of a cell-of-origin for fibroblasts comprising the fibrotic reticulum in idiopathic pulmonary fibrosis [published online ahead of print March 13, 2014]. Am J Pathol. http://dx.doi.org/10.1016/j.ajpath.2014.01.012.
18. P.W. Noble, C.E. Barkauskas, and D. Jiang Pulmonary fibrosis: patterns and perpetrators J Clin Invest 122 8 2012 2756 2762
19. T.M. Maher Beyond the diagnosis of idiopathic pulmonary fibrosis: the growing role of systems biology and stratified medicine Curr Opin Pulm Med 19 5 2013 460 465
20. C. Shimbori, J. Gauldie, and M. Kolb Extracellular matrix microenvironment contributes actively to pulmonary fibrosis Curr Opin Pulm Med 19 5 2013 446 452
21. J.K. Alder, J.J. Chen, and L. Lancaster et al. Short telomeres are a risk factor for idiopathic pulmonary fibrosis Proc Natl Acad Sci U S A 105 35 2008 13051 13056
22. M. Chilosi, A. Carloni, A. Rossi, and V. Poletti Premature lung aging and cellular senescence in the pathogenesis of idiopathic pulmonary fibrosis and COPD/emphysema Transl Res 162 3 2013 156 173
23. K.O. Leslie Idiopathic pulmonary fibrosis may be a disease of recurrent, tractional injury to the periphery of the aging lung: a unifying hypothesis regarding etiology and pathogenesis Arch Pathol Lab Med 136 6 2012 591 600
24. M.A. Seibold, A.L. Wise, and M.C. Speer et al. A common MUC5B promoter polymorphism and pulmonary fibrosis N Engl J Med 364 16 2011 1503 1512
25. A.L. Peljto, Y. Zhang, and T.E. Fingerlin et al. Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis JAMA 309 21 2013 2232 2239
26. M.Y. Armanios, J.J. Chen, and J.D. Cogan et al. Telomerase mutations in families with idiopathic pulmonary fibrosis N Engl J Med 356 13 2007 1317 1326
27. J.T. Cronkhite, C. Xing, and G. Raghu et al. Telomere shortening in familial and sporadic pulmonary fibrosis Am J Respir Crit Care Med 178 7 2008 729 737
28. T. Liu, M. Ullenbruch, and Y. Young Choi et al. Telomerase and telomere length in pulmonary fibrosis Am J Respir Cell Mol Biol 49 2 2013 260 268
29. A.Q. Thomas, K. Lane, and J. Phillips III et al. Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred Am J Respir Crit Care Med 165 9 2002 1322 1328
30. Y. Wang, P.J. Kuan, and C. Xing et al. Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer Am J Hum Genet 84 1 2009 52 59
31. E.R. Fernández Pérez, C.E. Daniels, and D.R. Schroeder et al. Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study Chest 137 1 2010 129 137
32. G. Raghu, D. Weycker, J. Edelsberg, W.Z. Bradford, and G. Oster Incidence and prevalence of idiopathic pulmonary fibrosis Am J Respir Crit Care Med 174 7 2006 810 816
33. W.W. Douglas, J.H. Ryu, and D.R. Schroeder Idiopathic pulmonary fibrosis: impact of oxygen and colchicine, prednisone, or no therapy on survival Am J Respir Crit Care Med 161 4, pt 1 2000 1172 1178
34. T.E. King Jr., J.A. Tooze, M.I. Schwarz, K.R. Brown, and R.M. Cherniack Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model Am J Respir Crit Care Med 164 7 2001 1171 1181
35. H.F. Nadrous, J.L. Myers, P.A. Decker, and J.H. Ryu Idiopathic pulmonary fibrosis in patients younger than 50 years Mayo Clin Proc 80 1 2005 37 40
36. J.S. Allam, and A.H. Limper Idiopathic pulmonary fibrosis: is it a familial disease? Curr Opin Pulm Med 12 5 2006 312 317
37. M.P. Steele, M.C. Speer, and J.E. Loyd et al. Clinical and pathologic features of familial interstitial pneumonia Am J Respir Crit Care Med 172 9 2005 1146 1152
38. H.-L. Lee, J.H. Ryu, and M.H. Wittmer et al. Familial idiopathic pulmonary fibrosis: clinical features and outcome Chest 127 6 2005 2034 2041
39. M.M. Wahidi, M.C. Speer, M.P. Steele, K.K. Brown, M.I. Schwarz, and D.A. Schwartz Familial pulmonary fibrosis in the United States Chest 121 3, suppl 2002 30S
40. R. Borie, C. Kannengiesser, and B. Crestani Familial forms of nonspecific interstitial pneumonia/idiopathic pulmonary fibrosis: clinical course and genetic background Curr Opin Pulm Med 18 5 2012 455 461
41. V. Taskar, and D. Coultas Exposures and idiopathic lung disease Semin Respir Crit Care Med 29 6 2008 670 679
42. J. Behr, and J.H. Ryu Pulmonary hypertension in interstitial lung disease Eur Respir J 31 6 2008 1357 1367
43. S.D. Nathan, P.W. Noble, and R.M. Tuder Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots Am J Respir Crit Care Med 175 9 2007 875 880
44. Y. Zhang, and N. Kaminski Biomarkers in idiopathic pulmonary fibrosis Curr Opin Pulm Med 18 5 2012 441 446
45. R. Vij, and I. Noth Peripheral blood biomarkers in idiopathic pulmonary fibrosis Transl Res 159 4 2012 218 227
46. A. Tzouvelekis, G. Kouliatsis, S. Anevlavis, and D. Bouros Serum biomarkers in interstitial lung diseases Respir Res 6 2005 78
47. A. Prasse, and J. Müller-Quernheim Non-invasive biomarkers in pulmonary fibrosis Respirology 14 6 2009 788 795
48. C.I. Silva, and N.L. Müller Idiopathic interstitial pneumonias J Thorac Imaging 24 4 2009 260 273
49. D.A. Lynch, J.D. Godwin, S. Safrin Idiopathic Pulmonary Fibrosis Study Group High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis Am J Respir Crit Care Med 172 4 2005 488 493
50. H. Arakawa, and K. Honma Honeycomb lung: history and current concepts AJR Am J Roentgenol 196 4 2011 773 782
51. F.J. Martinez, and K. Flaherty Pulmonary function testing in idiopathic interstitial pneumonias Proc Am Thorac Soc 3 4 2006 315 321
52. V. Cottin, H. Nunes, P.Y. Brillet Groupe d'Etude et de Recherche sur les Maladies Orphelines Pulmonaires (GERM O P) Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity Eur Respir J 26 4 2005 586 593
53. M.D. Jankowich, and S.I. Rounds Combined pulmonary fibrosis and emphysema syndrome: a review Chest 141 1 2012 222 231
54. C.J. Ryerson, T. Hartman, and B.M. Elicker et al. Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis Chest 144 1 2013 234 240
55. S. Trahan, V. Hanak, J.H. Ryu, and J.L. Myers Role of surgical lung biopsy in separating chronic hypersensitivity pneumonia from usual interstitial pneumonia/idiopathic pulmonary fibrosis: analysis of 31 biopsies from 15 patients Chest 134 1 2008 126 132
56. S. Misumi, and D.A. Lynch Idiopathic pulmonary fibrosis/usual interstitial pneumonia: imaging diagnosis, spectrum of abnormalities, and temporal progression Proc Am Thorac Soc 3 4 2006 307 314
57. J.H. Ryu, C.E. Daniels, T.E. Hartman, and E.S. Yi Diagnosis of interstitial lung diseases Mayo Clin Proc 82 8 2007 976 986
58. K.O. Leslie, J.F. Gruden, J.M. Parish, and M.B. Scholand Transbronchial biopsy interpretation in the patient with diffuse parenchymal lung disease Arch Pathol Lab Med 131 3 2007 407 423
59. S. Ohshimo, F. Bonella, and A. Cui et al. Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis Am J Respir Crit Care Med 179 11 2009 1043 1047
60. G.L. Casoni, S. Tomassetti, and A. Cavazza et al. Transbronchial lung cryobiopsy in the diagnosis of fibrotic interstitial lung diseases PLoS One 9 2 2014 e86716
61. F. Maldonado, and J.H. Ryu Surgical biopsy for diffuse parenchymal lung diseases: are we causing more harm than good? J Bronchology Interv Pulmonol 16 4 2009 227 228
62. D.J. Riley, and E.J. Costanzo Surgical biopsy: its appropriateness in diagnosing interstitial lung disease Curr Opin Pulm Med 12 5 2006 331 336
63. S. Sharma Diagnosing idiopathic pulmonary fibrosis: to biopsy or not to biopsy [editorial] Curr Opin Pulm Med 18 5 2012 528 529
64. J.P. Utz, J.H. Ryu, and W.W. Douglas et al. High short-term mortality following lung biopsy for usual interstitial pneumonia Eur Respir J 17 2 2001 175 179
65. J.H. Park, D.K. Kim, and D.S. Kim et al. Mortality and risk factors for surgical lung biopsy in patients with idiopathic interstitial pneumonia Eur J Cardiothorac Surg 31 6 2007 1115 1119
66. K.R. Flaherty, T.E. King Jr., and G. Raghu et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am J Respir Crit Care Med 170 8 2004 904 910
67. M. Smith, M. Dalurzo, P. Panse, J. Parish, and K. Leslie Usual interstitial pneumonia-pattern fibrosis in surgical lung biopsies: clinical, radiological and histopathological clues to aetiology J Clin Pathol 66 10 2013 896 903
68. B. Ley, H.R. Collard, and T.E. King Jr. Clinical course and prediction of survival in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 183 4 2011 431 440
69. M. Selman, G. Carrillo, and A. Estrada et al. Accelerated variant of idiopathic pulmonary fibrosis: clinical behavior and gene expression pattern PLoS ONE 2 5 2007 e482
70. A.U. Wells, S.R. Desai, and M.B. Rubens et al. Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography Am J Respir Crit Care Med 167 7 2003 962 969
71. B. Ley, C.J. Ryerson, and E. Vittinghoff et al. A multidimensional index and staging system for idiopathic pulmonary fibrosis Ann Intern Med 156 10 2012 684 691
72. R.M. du Bois, D. Weycker, and C. Albera et al. Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis Am J Respir Crit Care Med 184 4 2011 459 466
73. C.E. Daniels, E.S. Yi, and J.H. Ryu Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis Eur Respir J 32 1 2008 170 174
74. R.J. Panos, R.L. Mortenson, S.A. Niccoli, and T.E. King Jr. Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment Am J Med 88 4 1990 396 404
75. H.R. Collard, B.B. Moore, K.R. Flaherty Idiopathic Pulmonary Fibrosis Clinical Research Network Investigators Acute exacerbations of idiopathic pulmonary fibrosis Am J Respir Crit Care Med 176 7 2007 636 643
76. J.G. Parambil, J.L. Myers, and J.H. Ryu Histopathologic features and outcome of patients with acute exacerbation of idiopathic pulmonary fibrosis undergoing surgical lung biopsy Chest 128 5 2005 3310 3315
77. G. Saydain, A. Islam, B. Afessa, J.H. Ryu, J.P. Scott, and S.G. Peters Outcome of patients with idiopathic pulmonary fibrosis admitted to the intensive care unit Am J Respir Crit Care Med 166 6 2002 839 842
78. D.S. Kim Acute exacerbation of idiopathic pulmonary fibrosis Clin Chest Med 33 1 2012 59 68
79. M. Mejía, G. Carrillo, and J. Rojas-Serrano et al. Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension Chest 136 1 2009 10 15
80. V. Cottin, J. Le Pavec, G. Prévot GERM"O"P Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome Eur Respir J 35 1 2010 105 111
81. C.D. Fell Idiopathic pulmonary fibrosis: phenotypes and comorbidities Clin Chest Med 33 1 2012 51 57
82. J. Gagermeier, J. Dauber, S. Yousem, K. Gibson, and N. Kaminski Abnormal vascular phenotypes in patients with idiopathic pulmonary fibrosis and secondary pulmonary hypertension Chest 128 6, suppl 2005 601S
83. L. Farkas, J. Gauldie, N.F. Voelkel, and M. Kolb Pulmonary hypertension and idiopathic pulmonary fibrosis: a tale of angiogenesis, apoptosis, and growth factors Am J Respir Cell Mol Biol 45 1 2011 1 15
84. L. Kolilekas, E. Manali, and K.A. Vlami et al. Sleep oxygen desaturation predicts survival in idiopathic pulmonary fibrosis J Clin Sleep Med 9 6 2013 593 601
85. S. Gläser, A. Obst, and B. Koch et al. Pulmonary hypertension in patients with idiopathic pulmonary fibrosis - the predictive value of exercise capacity and gas exchange efficiency PLoS ONE 8 6 2013 e65643
86. Idiopathic Pulmonary Fibrosis Clinical Research Network D.A. Zisman, M. Schwarz, K.J. Anstrom, H.R. Collard, K.R. Flaherty, and G.W. Hunninghake A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis N Engl J Med 363 7 2010 620 628
87. T.E. King Jr., K.K. Brown, and G. Raghu et al. BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 184 1 2011 92 99
88. G. Raghu, J. Behr, K.K. Brown ARTEMIS-IPF Investigators Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial Ann Intern Med 158 9 2013 641 649
89. G. Raghu, R. Million-Rousseau, A. Morganti, L. Perchenet, J. Behr MUSIC Study Group Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trial Eur Respir J 42 6 2013 1622 1632
90. G. Raghu, T.D. Freudenberger, and S. Yang et al. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis Eur Respir J 27 1 2006 136 142
91. R.W. Tobin, C.E. Pope II, C.A. Pellegrini, M.J. Emond, J. Sillery, and G. Raghu Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis Am J Respir Crit Care Med 158 6 1998 1804 1808
92. M.P. Sweet, M.G. Patti, and L.E. Leard et al. Gastroesophageal reflux in patients with idiopathic pulmonary fibrosis referred for lung transplantation J Thorac Cardiovasc Surg 133 4 2007 1078 1084
93. E. Savarino, R. Carbone, and E. Marabotto et al. Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients Eur Respir J 42 5 2013 1322 1331
94. J.S. Lee, J.W. Song, and P.J. Wolters et al. Bronchoalveolar lavage pepsin in acute exacerbation of idiopathic pulmonary fibrosis Eur Respir J 39 2 2012 352 358
95. J.S. Lee, J.H. Ryu, and B.M. Elicker et al. Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis Am J Respir Crit Care Med 184 12 2011 1390 1394
96. J.S. Lee, H.R. Collard, K.J. Anstrom IPFnet Investigators Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials Lancet Respir Med 1 5 2013 369 376
97. P.A. Linden, R.J. Gilbert, and B.Y. Yeap et al. Laparoscopic fundoplication in patients with end-stage lung disease awaiting transplantation J Thorac Cardiovasc Surg 131 2 2006 438 446
98. R.D. Davis Jr., C.L. Lau, and S. Eubanks et al. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation J Thorac Cardiovasc Surg 125 3 2003 533 542
99. E. Cantu III, J.Z. Appel III, and M.G. Hartwig et al. Early fundoplication prevents chronic allograft dysfunction in patients with gastroesophageal reflux disease Ann Thorac Surg 78 4 2004 1142 1151
100. R. Hubbard, A. Venn, S. Lewis, and J. Britton Lung cancer and cryptogenic fibrosing alveolitis: a population-based cohort study Am J Respir Crit Care Med 161 1 2000 5 8
101. M.C. Aubry, J.L. Myers, and W.W. Douglas et al. Primary pulmonary carcinoma in patients with idiopathic pulmonary fibrosis Mayo Clin Proc 77 8 2002 763 770
102. C.E. Daniels, and J.R. Jett Does interstitial lung disease predispose to lung cancer? Curr Opin Pulm Med 11 5 2005 431 437
103. I. Le Jeune, J. Gribbin, J. West, C. Smith, P. Cullinan, and R. Hubbard The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK Respir Med 101 12 2007 2534 2540
104. J.M. Harris, I.D. Johnston, R. Rudd, A.J. Taylor, and P. Cullinan Cryptogenic fibrosing alveolitis and lung cancer: the BTS study Thorax 65 1 2010 70 76
105. K. Kishi, S. Homma, A. Kurosaki, N. Motoi, and K. Yoshimura High-resolution computed tomography findings of lung cancer associated with idiopathic pulmonary fibrosis J Comput Assist Tomogr 30 1 2006 95 99
106. R. Yoshida, H. Arakawa, and Y. Kaji Lung cancer in chronic interstitial pneumonia: early manifestation from serial CT observations AJR Am J Roentgenol 199 1 2012 85 90
107. K. Kushibe, T. Kawaguchi, M. Takahama, M. Kimura, T. Tojo, and S. Taniguchi Operative indications for lung cancer with idiopathic pulmonary fibrosis Thorac Cardiovasc Surg 55 8 2007 505 508
108. J.S. Park, H.K. Kim, K. Kim, J. Kim, Y.M. Shim, and Y.S. Choi Prediction of acute pulmonary complications after resection of lung cancer in patients with preexisting interstitial lung disease Thorac Cardiovasc Surg 59 3 2011 148 152
109. R.C. Chambers, and C.J. Scotton Coagulation cascade proteinases in lung injury and fibrosis Proc Am Thorac Soc 9 3 2012 96 101
110. R.B. Hubbard, C. Smith, I. Le Jeune, J. Gribbin, and A.W. Fogarty The association between idiopathic pulmonary fibrosis and vascular disease: a population-based study Am J Respir Crit Care Med 178 12 2008 1257 1261
111. B.F. Sode, M. Dahl, S.F. Nielsen, and B.G. Nordestgaard Venous thromboembolism and risk of idiopathic interstitial pneumonia: a nationwide study Am J Respir Crit Care Med 181 10 2010 1085 1092
112. D.B. Sprunger, A.L. Olson, and T.J. Huie et al. Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease Eur Respir J 39 1 2012 125 132
113. J. Gauldie Pro: inflammatory mechanisms are a minor component of the pathogenesis of idiopathic pulmonary fibrosis Am J Respir Crit Care Med 165 9 2002 1205 1206
114. Idiopathic Pulmonary Fibrosis Clinical Research Network Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis N Engl J Med 366 21 2012 1968 1977
115. W.W. Douglas, J.H. Ryu, and J.A. Bjoraker et al. Colchicine versus prednisone as treatment of usual interstitial pneumonia Mayo Clin Proc 72 3 1997 201 209
116. R. Ziesche, E. Hofbauer, K. Wittmann, V. Petkov, and L.H. Block A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis N Engl J Med 341 17 1999 1264 1269
117. G. Gurujeyalakshmi, and S.N. Giri Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: downregulation of TGF-beta and procollagen I and III gene expression Exp Lung Res 21 5 1995 791 808
118. G. Raghu, K.K. Brown, W.Z. Bradford Idiopathic Pulmonary Fibrosis Study Group A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis N Engl J Med 350 2 2004 125 133
119. T.E. King Jr., C. Albera, W.Z. Bradford INSPIRE Study Group Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial Lancet 374 9685 2009 222 228
120. G. Raghu, K.K. Brown, and U. Costabel et al. Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial Am J Respir Crit Care Med 178 9 2008 948 955
121. C.E. Daniels, J.A. Lasky, A.H. Limper, K. Mieras, E. Gabor, D.R. Schroeder Imatinib-IPF Study Investigators Imatinib treatment for idiopathic pulmonary fibrosis: randomized placebo-controlled trial results Am J Respir Crit Care Med 181 6 2010 604 610
122. H. Kubo, K. Nakayama, and M. Yanai et al. Anticoagulant therapy for idiopathic pulmonary fibrosis Chest 128 3 2005 1475 1482
123. I. Noth, K.J. Anstrom, S.B. Calvert Idiopathic Pulmonary Fibrosis Clinical Research Network (IPFnet) A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 186 1 2012 88 95
124. M. Demedts, J. Behr, R. Buhl IFIGENIA Study Group High-dose acetylcysteine in idiopathic pulmonary fibrosis N Engl J Med 353 21 2005 2229 2242
125. H.R. Collard, K.J. Anstrom, M.I. Schwarz, and D.A. Zisman Sildenafil improves walk distance in idiopathic pulmonary fibrosis Chest 131 3 2007 897 899
126. T.E. King Jr., J. Behr, and K.K. Brown et al. BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 177 1 2008 75 81
127. A. Azuma, T. Nukiwa, and E. Tsuboi et al. Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis Am J Respir Crit Care Med 171 9 2005 1040 1047
128. H. Taniguchi, M. Ebina, Y. Kondoh Pirfenidone Clinical Study Group in Japan Pirfenidone in idiopathic pulmonary fibrosis Eur Respir J 35 4 2010 821 829
129. P.W. Noble, C. Albera, W.Z. Bradford CAPACITY Study Group Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials Lancet 377 9779 2011 1760 1769
130. J.S. Lee, H.R. Collard, and G. Raghu et al. Does chronic microaspiration cause idiopathic pulmonary fibrosis? Am J Med 123 4 2010 304 311
131. C.J. Ryerson, D. Donesky, S.Z. Pantilat, and H.R. Collard Dyspnea in idiopathic pulmonary fibrosis: a systematic review J Pain Symptom Manage 43 4 2012 771 782
132. L.H. Lancaster, W.R. Mason, and J.A. Parnell et al. Obstructive sleep apnea is common in idiopathic pulmonary fibrosis Chest 136 3 2009 772 778
133. A.E. Holland, C.J. Hill, M. Conron, P. Munro, and C.F. McDonald Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease Thorax 63 6 2008 549 554
134. J.J. Swigris, D.L. Fairclough, and M. Morrison et al. Benefits of pulmonary rehabilitation in idiopathic pulmonary fibrosis [published correction appears in Respir Care. 2013;58(4):e51] Respir Care 56 6 2011 783 789
135. P. Huppmann, B. Sczepanski, and M. Boensch et al. Effects of inpatient pulmonary rehabilitation in patients with interstitial lung disease Eur Respir J 42 2 2013 444 453
136. K.K. Brown Chronic cough due to chronic interstitial pulmonary diseases: ACCP evidence-based clinical practice guidelines Chest 129 1, suppl 2006 180S 185S
137. B.D. Hope-Gill, S. Hilldrup, C. Davies, R.P. Newton, and N.K. Harrison A study of the cough reflex in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 168 8 2003 995 1002
138. M.R. Horton, V. Santopietro, and L. Mathew et al. Thalidomide for the treatment of cough in idiopathic pulmonary fibrosis: a randomized trial Ann Intern Med 157 6 2012 398 406
139. T. Fumeaux, C. Rothmeier, and P. Jolliet Outcome of mechanical ventilation for acute respiratory failure in patients with pulmonary fibrosis Intensive Care Med 27 12 2001 1868 1874
140. J.B. Stern, H. Mal, and O. Groussard et al. Prognosis of patients with advanced idiopathic pulmonary fibrosis requiring mechanical ventilation for acute respiratory failure Chest 120 1 2001 213 219
141. G. Thabut, H. Mal, and Y. Castier et al. Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis J Thorac Cardiovasc Surg 126 2 2003 469 475
142. D. Keating, B. Levvey, and T. Kotsimbos et al. Lung transplantation in pulmonary fibrosis: challenging early outcomes counterbalanced by surprisingly good outcomes beyond 15 years Transplant Proc 41 1 2009 289 291